Next-gen therapies for cancer and dementia fast-tracked with new facility
By Liz Wells 28 August 2025
The UK government is to invest £29.6m in a new facility that will springboard new RNA therapies, which could help tackle cancer, heart conditions, and other diseases.
DoLS Coordinator
Grade 6, £26,825 to £28,142 per annum pro-rata (actual salary £15,950 to £16,733.08)
Newport, Isle of WightGrade 6, £26,825 to £28,142 per annum pro-rata (actual salary £15,950 to £16,733.08)
Head of Service – Social Care
£60k pa plus International Supplement
Saint Helena, Ascension and Tristan da Cunha (SH)£60k pa plus International Supplement
Lead Child Protection Practitioner
£54,143 - £56,293 per annum
Gloucestershire £54,143 - £56,293 per annum
Most Read News
- EXCLUSIVE: The NHS operating model will be judged on delivery, not structures
- NHS waiting list rises fourth time in five months
- NCA makes new offer to resolve industrial dispute
- BREAKING NEWS: Dr Birju Bartoli and James Benson join NHS England leadership
- UK invests £33.2m in vaccines to tackle future epidemic threats
DoLS Coordinator
Grade 6, £26,825 to £28,142 per annum pro-rata (actual salary £15,950 to £16,733.08)
Newport, Isle of WightGrade 6, £26,825 to £28,142 per annum pro-rata (actual salary £15,950 to £16,733.08)
Head of Service – Social Care
£60k pa plus International Supplement
Saint Helena, Ascension and Tristan da Cunha (SH)£60k pa plus International Supplement
Lead Child Protection Practitioner
£54,143 - £56,293 per annum
Gloucestershire £54,143 - £56,293 per annum
Most Read News
- EXCLUSIVE: The NHS operating model will be judged on delivery, not structures
- NHS waiting list rises fourth time in five months
- NCA makes new offer to resolve industrial dispute
- BREAKING NEWS: Dr Birju Bartoli and James Benson join NHS England leadership
- UK invests £33.2m in vaccines to tackle future epidemic threats
©2026 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
